balsalazide has been researched along with Cancer of Colon in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gum, JR; Hayes, A; Johnson, LK; Kim, YS; McQuaid, KR; Sleisenger, MH; Terdiman, JP; Weinberg, VK | 1 |
| Johnson, LK; Kim, YS; MacGregor, DJ; Sleisenger, MH | 1 |
1 trial(s) available for balsalazide and Cancer of Colon
| Article | Year |
|---|---|
Chemoprevention of colonic polyps with balsalazide: an exploratory, double-blind, placebo-controlled study.
Topics: Adenoma; Aged; Apoptosis; Colon, Sigmoid; Colonic Neoplasms; Colonic Polyps; Double-Blind Method; Gastrointestinal Agents; Humans; Male; Mesalamine; Middle Aged; Phenylhydrazines; Prospective Studies | 2009 |
1 other study(ies) available for balsalazide and Cancer of Colon
| Article | Year |
|---|---|
Chemoprevention of colon cancer carcinogenesis by balsalazide: inhibition of azoxymethane-induced aberrant crypt formation in the rat colon and intestinal tumor formation in the B6-Min/+ mouse.
Topics: Aminosalicylic Acids; Animals; Anti-Ulcer Agents; Anticarcinogenic Agents; Azoxymethane; Cell Division; Colonic Neoplasms; Genes, APC; Humans; Indomethacin; Intestinal Mucosa; Intestinal Neoplasms; Mesalamine; Mice; Mice, Mutant Strains; Phenylhydrazines; Prodrugs; Rats; Rats, Inbred F344; Tumor Cells, Cultured | 2000 |